| CIRAX | MFWLX | CIRAX / MFWLX | |
| Total Expense Ratio | 0.60 | 0.77 | 78% |
| Annual Report Gross Expense Ratio | 0.60 | 0.86 | 70% |
| Fund Existence | 24 years | 14 years | - |
| Gain YTD | 10.461 | 8.659 | 121% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 128B | 1.25B | 10,273% |
| Annual Yield % from dividends | 2.73 | 3.08 | 89% |
| Returns for 1 year | 13.22 | 9.69 | 136% |
| Returns for 3 years | 41.32 | 19.56 | 211% |
| Returns for 5 years | 44.17 | 2.86 | 1,544% |
| Returns for 10 years | 96.22 | 34.69 | 277% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CDVZX | 21.01 | 0.12 | +0.57% |
| Columbia Intrinsic Value Institutional | |||
| TRIPX | 31.30 | N/A | N/A |
| Nuveen International Eq Idx Premier | |||
| FBDIX | 197.95 | N/A | N/A |
| Franklin Biotechnology Discovery A | |||
| ABWCX | 16.27 | N/A | N/A |
| AB All Market Total Return C | |||
| SNORX | 41.27 | N/A | N/A |
| Easterly Snow Long/Short Opportunity R6 | |||